These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34938774)

  • 1. Prognostic Value of mRNAsi/Corrected mRNAsi Calculated by the One-Class Logistic Regression Machine-Learning Algorithm in Glioblastoma Within Multiple Datasets.
    Zhang M; Chen H; Liang B; Wang X; Gu N; Xue F; Yue Q; Zhang Q; Hong J
    Front Mol Biosci; 2021; 8():777921. PubMed ID: 34938774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
    Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
    Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
    Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Prognostic Model and Biomarkers for Cancer Stem Cell Characteristics in Glioblastoma by Network Analysis of Multi-Omics Data and Stemness Indices.
    Du J; Yan X; Mi S; Li Y; Ji H; Hou K; Ma S; Ba Y; Zhou P; Chen L; Xie R; Hu S
    Front Cell Dev Biol; 2020; 8():558961. PubMed ID: 33195193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative Analysis of Gene Expression Through One-Class Logistic Regression Machine Learning Identifies Stemness Features in Multiple Myeloma.
    Ban C; Yang F; Wei M; Liu Q; Wang J; Chen L; Lu L; Xie D; Liu L; Huang J
    Front Genet; 2021; 12():666561. PubMed ID: 34484287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma.
    Tian X; Zheng J; Mou W; Lu G; Chen S; Du J; Zheng Y; Chen S; Shen B; Li J; Wang N
    Front Pharmacol; 2022; 13():939542. PubMed ID: 35935823
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis.
    Pei J; Wang Y; Li Y
    J Transl Med; 2020 Feb; 18(1):74. PubMed ID: 32050983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depiction of tumor stemlike features and underlying relationships with hazard immune infiltrations based on large prostate cancer cohorts.
    Zhang C; Chen T; Li Z; Liu A; Xu Y; Gao Y; Xu D
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32856039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses.
    Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q
    Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
    Xu Q; Xu H; Chen S; Huang W
    Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
    [No Abstract]   [Full Text] [Related]  

  • 11. Exploring the role of tumor stemness and the potential of stemness-related risk model in the prognosis of intrahepatic cholangiocarcinoma.
    Yue Y; Tao J; An D; Shi L
    Front Genet; 2022; 13():1089405. PubMed ID: 36712866
    [No Abstract]   [Full Text] [Related]  

  • 12. Implications of Stemness Features in 1059 Hepatocellular Carcinoma Patients from Five Cohorts: Prognosis, Treatment Response, and Identification of Potential Compounds.
    Mai H; Xie H; Luo M; Hou J; Chen J; Hou J; Jiang DK
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of stemness features and construction of a stemness subtype classifier to predict survival and treatment responses in lung squamous cell carcinoma.
    Lai J; Lin X; Zheng H; Xie B; Fu D
    BMC Cancer; 2023 Jun; 23(1):525. PubMed ID: 37291533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a novel mRNAsi-related risk model for predicting prognosis and immunotherapy response in osteosarcoma.
    Li Z; Jin C; Lu X; Zhang Y; Zhang Y; Wen J; Liu Y; Liu X; Li J
    Ann Transl Med; 2023 Jan; 11(2):61. PubMed ID: 36819514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma].
    Zheng J; Zhang YW; Pan ZF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):685-695. PubMed ID: 34728029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative analysis of gene expression and DNA methylation through one-class logistic regression machine learning identifies stemness features in medulloblastoma.
    Lian H; Han YP; Zhang YC; Zhao Y; Yan S; Li QF; Wang BC; Wang JJ; Meng W; Yang J; Wang QH; Mao WW; Ma J
    Mol Oncol; 2019 Oct; 13(10):2227-2245. PubMed ID: 31385424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell index-based RiskScore model for predicting prognosis in thyroid cancer and experimental verification.
    Chen R; Gao W; Liang L; Yu H; Song W
    Heliyon; 2024 Jun; 10(11):e31970. PubMed ID: 38868069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mRNAsi-related genes can effectively distinguish hepatocellular carcinoma into new molecular subtypes.
    Wang C; Qin S; Pan W; Shi X; Gao H; Jin P; Xia X; Ma F
    Comput Struct Biotechnol J; 2022; 20():2928-2941. PubMed ID: 35765647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyzing mRNAsi-Related Genes Identifies Novel Prognostic Markers and Potential Drug Combination for Patients with Basal Breast Cancer.
    Huang K; Wu Y; Xie Y; Huang L; Liu H
    Dis Markers; 2021; 2021():4731349. PubMed ID: 34646403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Stemness Associated With Prognosis and the Efficacy of Immunotherapy in Adrenocortical Carcinoma.
    Shi X; Liu Y; Cheng S; Hu H; Zhang J; Wei M; Zhao L; Xin S
    Front Oncol; 2021; 11():651622. PubMed ID: 34367952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.